Trop2-Based Antibody–Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy.
Simple Summary: With the aim of providing evidence-based insights for improved prognosis in TNBC patients, this article conducts a systematic review of the clinical research progress of Trop2-targeted ADCs. Trop2-targeted therapies are set to become a cornerstone of precision medicine for solid tumo...
| Publicado en: | Current Oncology Vol. 31; no. 2; pp. 92 - 110 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Feb2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |